Healthcare >> CEO Interviews >> February 10, 2014
David Pritchard, KaloBios Pharmaceuticals, Inc.’s President and CEO since 2006, has had an over 25-year career within the biopharmaceutical industry. Before joining KaloBios Pharmaceuticals, Inc., he was Chief Business Officer at Rinat Neuroscience Corporation, where he managed the company’s acquisition by Pfizer. Prior to that, he was Chief Financial Officer at Matrix Pharmaceuticals, and managed that firm’s sale to Chiron Corporation, now Novartis. He also previously served for eight years as Vice President, Business Development and CFO of Metabolex, where he completed three rounds of financing and negotiated four worldwide corporate alliances. He began his biopharmaceutical career as a founding Manager of Triton Biosciences. Profile
Mr. Pritchard: KaloBios is a biopharmaceutical company that is developing patient-targeted therapies based on
